<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: The presence of <z:hpo ids='HP_0001250'>seizure</z:hpo> at <z:hpo ids='HP_0001297'>stroke</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo> is a contraindication for intravenous tissue plasminogen activator treatment </plain></SENT>
<SENT sid="1" pm="."><plain>A significant proportion of these patients' deficits are not attributable to Todd's <z:hpo ids='HP_0003470'>paralysis</z:hpo> and could be attributable to reversible <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Currently there are no established methods of differentiating Todd's <z:hpo ids='HP_0003470'>paralysis</z:hpo> from <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo>/early <z:hpo ids='HP_0001250'>seizure</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>We sought to determine whether computed tomographic angiography (CTA) can be helpful in differentiating the 2 </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Three hundred and twenty six patients underwent noncontrast CT and CTA for <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> at our institution over 3 years (June 2002 to April 2005) </plain></SENT>
<SENT sid="5" pm="."><plain>Of them, 116 had disabling deficits and presented within 3 hours </plain></SENT>
<SENT sid="6" pm="."><plain>We reviewed the clinical data, noncontrast CT, CTA, electroencephalogram and outcome of these patients and identified those who presented with presumed <z:hpo ids='HP_0001250'>seizure</z:hpo> activity at <z:hpo ids='HP_0001297'>stroke</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo> (<z:hpo ids='HP_0001250'>seizure</z:hpo> or altered consciousness at <z:hpo ids='HP_0001297'>stroke</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo>) </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Nine (7.7%) patients had a concern of <z:hpo ids='HP_0001250'>seizure</z:hpo> at <z:hpo ids='HP_0001297'>stroke</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Median age 73 years (range, 31 to 85 years), median National Institutes of Health <z:hpo ids='HP_0001297'>Stroke</z:hpo> Scale (NIHSS) score 12 (range, 5 to 29) </plain></SENT>
<SENT sid="9" pm="."><plain>CTA showed proximal middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in 2 and distal middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in 3 patients </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> 5 of these patients had evidence of infarction on follow-up (<z:hpo ids='HP_0001297'>stroke</z:hpo>+early <z:hpo ids='HP_0001250'>seizure</z:hpo> group-intracranial occlusion present) </plain></SENT>
<SENT sid="11" pm="."><plain>Three of these patients received intravenous tissue plasminogen activator because they were deemed to have "ischemic tissue at risk" </plain></SENT>
<SENT sid="12" pm="."><plain>Four patients had <z:mpath ids='MPATH_458'>normal</z:mpath> CT and CTA studies and recovered completely in 24 hours (Todd's <z:hpo ids='HP_0003470'>paralysis</z:hpo> only group-intracranial occlusion negative) </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: <z:hpo ids='HP_0001250'>Seizure</z:hpo> at <z:hpo ids='HP_0001297'>stroke</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo> was relatively uncommon in a consecutive cohort of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> patients </plain></SENT>
<SENT sid="14" pm="."><plain>CTA was a useful modality in differentiating Todd's <z:hpo ids='HP_0003470'>paralysis</z:hpo> from early <z:hpo ids='HP_0001250'>seizure</z:hpo> and <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> by detection of intracranial occlusion and may contribute to decision-making for thrombolysis </plain></SENT>
</text></document>